95 related articles for article (PubMed ID: 26786594)
1. Implementation of a pharmaceutical care programme for patients receiving new molecular-targeted agents in a clinical trial unit.
Riu G; Gaba L; Victoria I; Molas G; do Pazo F; Gómez B; Creus N; Vidal L
Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 26786594
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceutical care program for onco-hematologic outpatients: safety, efficiency and patient satisfaction.
Ribed A; Romero-Jiménez RM; Escudero-Vilaplana V; Iglesias-Peinado I; Herranz-Alonso A; Codina C; Sanjurjo-Sáez M
Int J Clin Pharm; 2016 Apr; 38(2):280-8. PubMed ID: 26715547
[TBL] [Abstract][Full Text] [Related]
3. A randomized controlled trial of the feasibility and preliminary efficacy of a texting intervention on medication adherence in adults prescribed oral anti-cancer agents: study protocol.
Spoelstra SL; Given CW; Sikorskii A; Coursaris CK; Majumder A; DeKoekkoek T; Schueller M; Given BA
J Adv Nurs; 2015 Dec; 71(12):2965-76. PubMed ID: 26100719
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of a Text Messaging Intervention to Promote Self-Management for Patients Prescribed Oral Anticancer Agents.
Spoelstra SL; Given CW; Sikorskii A; Coursaris CK; Majumder A; DeKoekkoek T; Schueller M; Given BA
Oncol Nurs Forum; 2015 Nov; 42(6):647-57. PubMed ID: 26488833
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness of a nursing discharge programme to improve medication adherence and patient satisfaction in the psychiatric intensive care unit.
Virgolesi M; Pucciarelli G; Colantoni AM; D'Andrea F; Di Donato B; Giorgi F; Landi L; Salustri E; Turci C; Proietti MG
J Clin Nurs; 2017 Dec; 26(23-24):4456-4466. PubMed ID: 28233457
[TBL] [Abstract][Full Text] [Related]
6. [Novel oral anticancer drugs: a review of adverse drug reactions, interactions and patient adherence].
Bartal A; Mátrai Z; Szucs A; Belinszkaja G; Langmár Z; Rosta A
Orv Hetil; 2012 Jan; 153(2):66-78. PubMed ID: 22217686
[TBL] [Abstract][Full Text] [Related]
7. The (cost-)effectiveness of a patient-tailored intervention programme to enhance adherence to antihypertensive medication in community pharmacies: study protocol of a randomised controlled trial.
van der Laan DM; Elders PJ; Boons CC; Bosmans JE; Nijpels G; Hugtenburg JG
Trials; 2017 Jan; 18(1):29. PubMed ID: 28103948
[TBL] [Abstract][Full Text] [Related]
8. Development and Psychometric Testing of the Turkish-Version Oral Chemotherapy Adherence Scale.
Bagcivan G; Akbayrak N
J Nurs Res; 2015 Dec; 23(4):243-51. PubMed ID: 26562455
[TBL] [Abstract][Full Text] [Related]
9. A trial examining an advanced practice nurse intervention to promote medication adherence and symptom management in adult cancer patients prescribed oral anti-cancer agents: study protocol.
Spoelstra SL; Burhenn PS; DeKoekkoek T; Schueller M
J Adv Nurs; 2016 Feb; 72(2):409-20. PubMed ID: 26463113
[TBL] [Abstract][Full Text] [Related]
10. The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents.
Dürr P; Schlichtig K; Kelz C; Deutsch B; Maas R; Eckart MJ; Wilke J; Wagner H; Wolff K; Preuß C; Brückl V; Meidenbauer N; Staerk C; Mayr A; Fietkau R; Goebell PJ; Kunath F; Beckmann MW; Mackensen A; Neurath MF; Pavel M; Dörje F; Fromm MF
J Clin Oncol; 2021 Jun; 39(18):1983-1994. PubMed ID: 33822650
[TBL] [Abstract][Full Text] [Related]
11. Feasibility pilot on medication adherence and knowledge in ambulatory patients with gastrointestinal cancer.
Sommers RM; Miller K; Berry DL
Oncol Nurs Forum; 2012 Jul; 39(4):E373-9. PubMed ID: 22750908
[TBL] [Abstract][Full Text] [Related]
12. [Patient's beliefs about oral targeted therapies and impact on drug adherence in lung cancer: A pilot prospective study].
Torrecillas S; Perrot E; Gérinière L; Locatelli-Sanchez M; Laffay L; Souquet PJ; Couraud S
Rev Pneumol Clin; 2016 Feb; 72(1):25-34. PubMed ID: 26210879
[TBL] [Abstract][Full Text] [Related]
13. A pilot study of an automated voice response system and nursing intervention to monitor adherence to oral chemotherapy agents.
Decker V; Spoelstra S; Miezo E; Bremer R; You M; Given C; Given B
Cancer Nurs; 2009; 32(6):E20-9. PubMed ID: 19816160
[TBL] [Abstract][Full Text] [Related]
14. Drug interactions with oral antineoplastic drugs: The role of the pharmacist.
Riu-Viladoms G; Carcelero San Martín E; Martín-Conde MT; Creus N
Eur J Cancer Care (Engl); 2019 Jan; 28(1):e12944. PubMed ID: 30324634
[TBL] [Abstract][Full Text] [Related]
15. Drug-related problems with targeted/immunotherapies at an oncology outpatient clinic.
Kucuk E; Bayraktar-Ekincioglu A; Erman M; Kilickap S
J Oncol Pharm Pract; 2020 Apr; 26(3):595-602. PubMed ID: 31342849
[TBL] [Abstract][Full Text] [Related]
16. [Development of a standardized guide for optimizing drug adherence information to be dispensed during a pharmaceutical counseling with a multiple myeloma patient: Initial validation].
Favier-Archinard C; Leguelinel-Blache G; Dubois F; Le Gall T; Bourquard P; Passemard N; Tora S; Rey A; Rossi M; Chevallier T; Cousin C; Favier M
Bull Cancer; 2018 May; 105(5):475-485. PubMed ID: 29573809
[TBL] [Abstract][Full Text] [Related]
17. [Adherence to oral antineoplastic therapy].
Olivera-Fernandez R; Fernandez-Ribeiro F; Piñeiro-Corrales G; Crespo-Diz C
Farm Hosp; 2014 Nov; 38(6):475-81. PubMed ID: 25542658
[TBL] [Abstract][Full Text] [Related]
18. Oral targeted therapies: managing drug interactions, enhancing adherence and optimizing medication safety in lymphoma patients.
Liewer S; Huddleston AN
Expert Rev Anticancer Ther; 2015 Apr; 15(4):453-64. PubMed ID: 25683755
[TBL] [Abstract][Full Text] [Related]
19. An intervention to improve adherence and management of symptoms for patients prescribed oral chemotherapy agents: an exploratory study.
Spoelstra SL; Given BA; Given CW; Grant M; Sikorskii A; You M; Decker V
Cancer Nurs; 2013; 36(1):18-28. PubMed ID: 23235499
[TBL] [Abstract][Full Text] [Related]
20. Prospective evaluation of an anti-cancer drugs management programme in a dedicated oral therapy center (DICTO programme).
Deluche E; Darbas T; Bourcier K; Montangon L; Bayard G; Caille E; Querrioux J; Suchaud C; Zabaleta S; Chaput S; Le Brun-Ly V; Pestre J; Venat L; Thuillier F; Nevado E; Maillan G; Jost J; Leobon S; Tubiana-Mathieu N; Lavau-Denes S
Med Oncol; 2020 Jul; 37(8):69. PubMed ID: 32712771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
